Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aclaris Therapeutics, Inc. - Common Stock
(NQ:
ACRS
)
2.900
+0.010 (+0.35%)
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
499,772
Open
2.960
Bid (Size)
2.800 (52)
Ask (Size)
2.980 (6)
Prev. Close
2.890
Today's Range
2.840 - 2.965
52wk Range
0.8555 - 5.170
Shares Outstanding
71,430,942
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy
December 23, 2024
HC Wainwright upgraded Aclaris Therapeutics (ACRS) to Buy with a $20 price target. Aclaris gains after licensing agreement with Biosion for potential best-in-class therapies for atopic dermatitis and...
Via
Benzinga
Santa Rally, January Effect, And Top Stock Picks
December 23, 2024
Explore December 23's top pre-market picks, macro insights, and Santa Rally opportunities with StoryTrading's 4-pillar strategy. Join the community for exclusive trade ideas!
Via
Talk Markets
Topics
Stocks / Equities
Performance
YTD
+176.19%
+176.19%
1 Month
-27.32%
-27.32%
3 Month
+150.00%
+150.00%
6 Month
+124.81%
+124.81%
1 Year
+176.19%
+176.19%
More News
Read More
This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
December 23, 2024
Via
Benzinga
Level Up Your Trading: Inside The 4-Pillar Strategy Behind Triple-Digit Returns
December 18, 2024
Via
Talk Markets
Topics
Stocks / Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 19, 2024
Via
Benzinga
Aclaris Therapeutics: Q4 Earnings Insights
February 27, 2024
Via
Benzinga
The Analyst Landscape: 4 Takes On Aclaris Therapeutics
January 11, 2024
Via
Benzinga
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
November 19, 2024
Via
Benzinga
War, Gold, And Opportunity: Uncovering Today’s Market Moves
November 19, 2024
Via
Talk Markets
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
Via
Benzinga
Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
July 23, 2024
Via
Benzinga
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
July 11, 2024
Via
MarketBeat
Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying
July 08, 2024
Via
Benzinga
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 24, 2024
Via
Benzinga
ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
March 14, 2024
Via
FinancialNewsMedia
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
March 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
January 22, 2024
Via
Benzinga
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 22, 2024
Via
Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today?
January 16, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.